Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Selected bisphenols and phthalates screened for estrogen and androgen disruption by in silico and in vitro methods

M. Dvorakova, K. Kejlová, M. Rucki, D. Jírová,

. 2018 ; 39 (5) : 409-416. [pub] -

Jazyk angličtina Země Švédsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19034806

OBJECTIVES: The aim of this study was to detect endocrine disruption potential of selected bisphenols and phthalates, compare in silico prediction with results from two in vitro methods and bring up-to-date information on development of EU legislation, available in vitro methods and biomechanisms involved in endocrine disruption. MATERIAL AND METHODS: In silico approach based on the OECD QSAR Toolbox was used for prediction of estrogen receptor α binding. OECD TG 455 assay and a yeast-based YES/YAS assay was used to determine the interactions with human estrogen (ERα) and androgen receptors. RESULTS: In silico results predicted the screened phthalates as non binders and bisphenols as very strong binders of the ERα. In vitro results differed from in silico prediction in several cases but exhibited concordance mainly for strong binders of ERα. Most of the substances exhibited parallel activity (agonist-antagonist) on both estrogen and androgen receptors. Agonistic studies showed the effective concentration of 10% activity (EC10) from 5.0E-07 for strong agonists (e.g. BPC, BPTMC). Cytotoxicity was observed after 48 h exposure of S. cerevisiae to BPFL, BPG, BPM, BPTMC in concentrations starting at 3.6E-05 mol/l. CONCLUSION: Our results suggest multiple parallel interactions of tested compounds and emphasize the importance of determination of an appropriate battery of in vitro methods that will include more receptors and will be appropriate to target specific molecular mechanisms involved in endocrine disruption. Results in agonistic studies indicate agonistic potential and are supported by results of antagonistic studies with consideration of possible multiple interactions.

000      
00000naa a2200000 a 4500
001      
bmc19034806
003      
CZ-PrNML
005      
20191015101256.0
007      
ta
008      
191007s2018 sw f 000 0|eng||
009      
AR
035    __
$a (PubMed)30664347
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sw
100    1_
$a Dvorakova, Marketa $u Charles University in Prague, Third Faculty of Medicine, Ruská 87, Prague, Czech Republic.
245    10
$a Selected bisphenols and phthalates screened for estrogen and androgen disruption by in silico and in vitro methods / $c M. Dvorakova, K. Kejlová, M. Rucki, D. Jírová,
520    9_
$a OBJECTIVES: The aim of this study was to detect endocrine disruption potential of selected bisphenols and phthalates, compare in silico prediction with results from two in vitro methods and bring up-to-date information on development of EU legislation, available in vitro methods and biomechanisms involved in endocrine disruption. MATERIAL AND METHODS: In silico approach based on the OECD QSAR Toolbox was used for prediction of estrogen receptor α binding. OECD TG 455 assay and a yeast-based YES/YAS assay was used to determine the interactions with human estrogen (ERα) and androgen receptors. RESULTS: In silico results predicted the screened phthalates as non binders and bisphenols as very strong binders of the ERα. In vitro results differed from in silico prediction in several cases but exhibited concordance mainly for strong binders of ERα. Most of the substances exhibited parallel activity (agonist-antagonist) on both estrogen and androgen receptors. Agonistic studies showed the effective concentration of 10% activity (EC10) from 5.0E-07 for strong agonists (e.g. BPC, BPTMC). Cytotoxicity was observed after 48 h exposure of S. cerevisiae to BPFL, BPG, BPM, BPTMC in concentrations starting at 3.6E-05 mol/l. CONCLUSION: Our results suggest multiple parallel interactions of tested compounds and emphasize the importance of determination of an appropriate battery of in vitro methods that will include more receptors and will be appropriate to target specific molecular mechanisms involved in endocrine disruption. Results in agonistic studies indicate agonistic potential and are supported by results of antagonistic studies with consideration of possible multiple interactions.
650    _2
$a androgeny $x metabolismus $7 D000728
650    _2
$a biotest $x metody $7 D001681
650    _2
$a endokrinní disruptory $x metabolismus $7 D052244
650    _2
$a alfa receptor estrogenů $x metabolismus $7 D047628
650    _2
$a estrogeny $x metabolismus $7 D004967
650    _2
$a lidé $7 D006801
650    _2
$a androgenní receptory $x metabolismus $7 D011944
650    _2
$a receptory pro estrogeny $x metabolismus $7 D011960
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kejlová, Kristina $u National Institute of Public Health, Centre of Toxicology and Health Safety, Šrobárova 48, Prague, Czech Republic.
700    1_
$a Rucki, Marian $u National Institute of Public Health, Centre of Toxicology and Health Safety, Šrobárova 48, Prague, Czech Republic.
700    1_
$a Jírová, Dagmar $u Charles University in Prague, Third Faculty of Medicine, Ruská 87, Prague, Czech Republic.
773    0_
$w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 39, č. 5 (2018), s. 409-416
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30664347 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191015101722 $b ABA008
999    __
$a ok $b bmc $g 1451466 $s 1073356
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 39 $c 5 $d 409-416 $e - $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
LZP    __
$a Pubmed-20191007

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...